Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2005
11/17/2005WO2004024087A3 Methods of diagnosing and treating hyperproliferative disorders
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005US20050257282 Plant centromere compositions
11/17/2005US20050257280 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
11/17/2005US20050257276 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/17/2005US20050256815 Medical applications of adaptive learning systems using gene expression data
11/17/2005US20050256652 Reconstruction of gene networks from time-series microarray data
11/17/2005US20050256525 Dilation introducer for orthopedic surgery
11/17/2005US20050256073 Immunostimulatory viral RNA oligonucleotides
11/17/2005US20050256072 Dual functional oligonucleotides for use in repressing mutant gene expression
11/17/2005US20050256071 Inhibitor nucleic acids
11/17/2005US20050256069 IRNA agents with biocleavable tethers
11/17/2005US20050256050 Vascular endothelial growth factor 2
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/17/2005US20050256046 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight
11/17/2005US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/17/2005US20050255596 Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
11/17/2005US20050255586 Pasting edge heater
11/17/2005US20050255576 PGDS inhibitor; antiallergies, sleep control, antiobesity and brain wound healing; Crystals of a complex of human origin hematopoietic prostaglandin D synthase, glutathione and a substrate analog or an inhibitor
11/17/2005US20050255574 Proteins
11/17/2005US20050255573 An in vitro method of maintaining a mouse or human pluripotent cell in a pluripotent state by increasing expression of a gene that encodes a factor which acts intracellularly and maintainspluripotency, where the factor is a polypeptide of the sequence of SEQ ID NO: 4; cultures
11/17/2005US20050255563 Method for plasmid preparation by conversion of open circular plasmid to supercoiled plasmid
11/17/2005US20050255559 Isolated nucleic acid molecule(s) encoding a human calcium sensitive potassium channel subunit protein designated beta2, encoded proteins, and uses thereof
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255548 Protein scaffolds for antibody mimics and other binding proteins
11/17/2005US20050255545 Regulation of human hematopoietin receptor-like protein
11/17/2005US20050255538 Methods for screening for AcrAB efflux pump inhibitors
11/17/2005US20050255536 Method of selectively measuring triglycerides
11/17/2005US20050255535 Assaying coagulation of a sample; accurate determination of the concentration of anticoagulant in a sample such as a blood or plasma sample
11/17/2005US20050255534 Using cyclooxygenase inhibitors to evaluate agonist activated blood and extracellular platelet-release
11/17/2005US20050255531 Signal transduction
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255527 screening for biological targets, using a combination of an enyzyme-linked immunoassay and electrochemiluminescence assay to identify antibodies or antigen binding fragments
11/17/2005US20050255525 Safe method for isolation of prion protein and diagnosis of transmissible spongiform encephalopathies
11/17/2005US20050255524 Microparticle-based methods and systems and applications thereof
11/17/2005US20050255523 Analyzing the identification and the concentration of particular target analytes; biological and chemical assays, receptor binding assay; bioassay of proteins, nucleic acids, peptide nucleic acids, biological cells, microorganisms
11/17/2005US20050255522 Method of determining biological/molecular age
11/17/2005US20050255520 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); specifically binds to polypeptide encoded by nucleic acid; labeled or conjugated to therapeutic agent; treatment of cardiovascular disorders
11/17/2005US20050255519 Reagents and methods useful for detecting diseases of the prostate
11/17/2005US20050255518 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
11/17/2005US20050255517 Methods and devices for multiplexing amplification reactions
11/17/2005US20050255516 Method for quantitative analysis of a nucleic acid amplification reaction
11/17/2005US20050255514 For depositing a monolayer of such silane molecules onto a substrate; such a monolayer of silane molecules may be used in biosensors, DNA/protein micro-arrays or other sensor applications
11/17/2005US20050255512 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
11/17/2005US20050255511 Fra-1 expression in brain cancer
11/17/2005US20050255510 Fra-1 expression in brain cancer
11/17/2005US20050255509 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
11/17/2005US20050255508 System, method and software arrangement for bi-allele haplotype phasing
11/17/2005US20050255507 Cytogenetically determined diagnosis and prognosis of proliferative disorders
11/17/2005US20050255506 NOS-2 and glaucoma
11/17/2005US20050255505 Classifying messenger nucleotide sequences and identifying junctions for use in prediciting peptide binding domains and protein active site; protein engineering
11/17/2005US20050255504 Using allelic variation in glutathione S-transferases (GSTs) genes as diagnostic/prognostic tool in detecting mammary gland cell proliferative disorders
11/17/2005US20050255503 Systems and methods for detecting and regulating metastasis
11/17/2005US20050255502 Screening agents which modulate formation of FANCD2-containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein
11/17/2005US20050255501 Method for gene identification signature (GIS) analysis
11/17/2005US20050255500 Determining subcellular distribution of Disrupted-in Schizophrenia-1 (DISC1) protein in cells to predict susceptibility of an individual to schizophrenia, bipolar disorder, major depression or substance abuse; haplotypes
11/17/2005US20050255499 Process for discrimination of nucleic acid sequence variants
11/17/2005US20050255498 APOC1 genetic markers associated with age of onset of Alzheimer's Disease
11/17/2005US20050255496 Ztnf12, a tumor necrosis factor
11/17/2005US20050255495 SLC5A7 genetic markers associated with age of onset of Alzheimer's disease
11/17/2005US20050255494 CDK5 genetic markers associated with galantamine response
11/17/2005US20050255492 CHRNA9 genetic markers associated with progression of Alzheimer's disease
11/17/2005US20050255491 Small molecule and peptide arrays and uses thereof
11/17/2005US20050255489 nucleotide sequence encoding a polypeptide having N-acetylglucosaminyl transferase V activity called Vb, useful in in vitro enzymatic reactions of this enzyme and in recombinant host cells for the production of glycoproteins with more efficient and extensive glycosylation
11/17/2005US20050255488 NTRK1 genetic markers associated with age of onset of Alzheimer's Disease
11/17/2005US20050255487 Methods and compositions for selecting siRNA of improved functionality
11/17/2005US20050255486 Methods for amplifying polymeric nucleic acids
11/17/2005US20050255485 Detection of gene duplications
11/17/2005US20050255484 Diagnostic markers of stroke and cerebral injury and methods of use thereof
11/17/2005US20050255483 System and method for smoothing melting curve data
11/17/2005US20050255482 analyzing a rearranged immunoglobulin or lymphocyte receptor variable region gene, characteristic of a clonal population of cells, using an amplification primer or hybridization probe that is specific to an individual gene segment; monitoring mammalian diseases
11/17/2005US20050255481 Progesterone receptor transcript sequences
11/17/2005US20050255480 A norovirus-permissive cell culture, including dendritic- and macrophage-lineage cells and macrophages having a deficiency in a cellular anti-viral pathway such as a STAT-1-dependent pathway, an interferon receptor-dependent pathway, or a PKR-dependent pathway infected with a norovirus
11/17/2005US20050255479 Method of detecting and predicting bronchodilatory response to beta agonist
11/17/2005US20050255477 Methods for high fidelity production of long nucleic acid molecules
11/17/2005US20050255476 Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
11/17/2005US20050255475 Energy transfer dyes, terminators and use thereof
11/17/2005US20050255474 Substrate for bioassay, substrate information reader, and substrate information reading method
11/17/2005US20050255473 Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
11/17/2005US20050255471 Method for analysis of transcription variations in a set of genes
11/17/2005US20050255470 determining the GPVI allelotype of subjects in need of surgery, with a low platelet count, with an acquired bleeding disorder, on blood thinning drugs, or of blood donors; diagnosis of an increased risk of bleeding
11/17/2005US20050255469 Human 5-ht7 receptor promoter sequence
11/17/2005US20050255468 Determination of the level of high risk HPV encoded gene-products such as e.g. HPV E2 and/or HPV E7 molecules in biological samples in the course of cytological testing procedures
11/17/2005US20050255467 Methods and computer program products for the quality control of nucleic acid assay
11/17/2005US20050255466 Method and system for determining absolute mrna quantities
11/17/2005US20050255465 Novel fluorescent label compounds
11/17/2005US20050255464 Methods for the identification of peptidyl compounds interacting with extracellular target molecules
11/17/2005US20050255463 Kits and methods for assessing leptin-mediated lipid metabolism
11/17/2005US20050255462 Screening library of compounds using plurality of bacteriophage displaying compound other than the polypeptide expressed by bacteriophage; heterologous nucleic acid tag is inserted into bacteriophage; assaying and decoding; drug screening; combinatorial chemistry; receptor binding assay
11/17/2005US20050255461 Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
11/17/2005US20050255460 Detecting presence of human papillomavirus E6 proteins using polypeptide comprising modular protein domains (PDZ); screening for cell proliferative disorders
11/17/2005US20050255459 Process and apparatus for using the sets of pseudo random subsequences present in genomes for identification of species
11/17/2005US20050255458 Drug discovery assays based on the biology of chronic disease
11/17/2005US20050255456 Method and apparatus for detection of bioaerosols
11/17/2005US20050255455 Eif4e gene mutations and potyvirus resistance
11/17/2005US20050255453 Multilayer reagent test strips and methods for using the same to quantify glycated protein in a physiological sample
11/17/2005US20050255452 Using reporter fusions as tools in monitoring protein-protein interactions
11/17/2005US20050255451 Toll-like receptor 9 modulators
11/17/2005US20050255450 contacting a yeast cell with a candidate agent, wherein the yeast cell expresses an alpha synuclein polypeptide and the cell does not express an endogenous wild-type gene, which causes or enhances toxicity associated with the presence of the alpha synuclein polypeptide
11/17/2005US20050255448 System for amplifying optical detection of cantilever deflection
1 ... 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 ... 3003